The central premise is that regularly recurring mechanical forces—such as those caused by breathing and pulsating blood flow—maintain the effectiveness of the cellular immune system.
“Cytotoxic T lymphocytes and natural killer cells are specialized in recognizing and killing infected or abnormal cells,” explains Prof. Dr. Bin Qu. Until now, biochemical messengers—particularly interleukin-2—have been considered crucial for their activation and function. “In a healthy body without inflammation, however, its concentration in the blood is extremely low. How immune cells maintain their readiness under these conditions has not yet been sufficiently clarified.”
The project “Cyclic mechanical forces sustain cytotoxic immune competence” is therefore investigating a factor that has received little attention to date: the repeated mechanical deformation to which immune cells are exposed during their circulation. The researchers have three objectives: They aim to determine which properties of cyclic forces influence the activity of natural killer cells and cytotoxic T lymphocytes. In addition, they are investigating which signaling pathways and gene activity programs translate mechanical stimuli into sustained immune function. Finally, they are investigating whether mechanical stimulation enables the activation of immune cells even in the presence of lower levels of signaling molecules or weaker recognition signals.
To this end, controlled mechanical stimulation experiments are combined with measurements of cellular killing activity and investigations of the underlying molecular processes. Comparisons between cyclic, static, and no stretching are intended to elucidate the specific effects of recurring forces.
“We expect to gain fundamental insights into whether and how physiological movement supports the immune defense under non-inflammatory conditions,” said Prof. Qu. The results could expand the current understanding of immune regulation—which has thus far been predominantly biochemical—and, in the long term, open up approaches to maintain or improve the performance of therapeutically deployed immune cells through targeted mechanical stimulation.
The nonprofit Boehringer Ingelheim Foundation is funding the project with a total of 599,960 € as part of its Rise up! program. The project is scheduled to begin on February 1, 2027; the funding period is 36 months.
Further information for the media:
Prof. Dr. Bin Qu, Osnabrück University
School of Human Sciences
bin.qu@uni-osnabrueck.de